LABS JUVISE
PharmaLABS JUVISE is a pharmaceutical company focused on Infectious Disease, Gastroenterology.
LABS JUVISE's Key Drugs
LABS JUVISE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
LABS JUVISE's Recent FDA Approvals
New NDA/BLA approvals for LABS JUVISE over the last two years — novel drugs only, excluding generics and label supplements.
LABS JUVISE's Therapeutic Areas
LABS JUVISE's approved drugs and pipeline span 2 therapeutic areas, led by Infectious Disease and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
LABS JUVISE's Top Competitors
LABS JUVISE's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
LABS JUVISE Pipeline Snapshot
Active clinical trials for LABS JUVISE across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-09-28
- Latest
- 2025-11-21
- Applications
- 1